Month: January 2023

Adoption of Innovative Solutions to Push Commercial Laundry Market to Reach USD 1.83 Billion by 2028

Written by Customer Service on January 9, 2023. Posted in Mergers And Acquisitions.

The commercial laundry market was valued at USD 1.40 billion in 2021, and it is expected to reach a value of USD 1.83 billion by 2028, at a CAGR of 3.40% over the forecast period (2022 – 2028). Westford, USA, Jan. 09, 2023 (GLOBE NEWSWIRE) — Growing consumer preference for card-based laundry payment systems over coin laundries, as well as the widespread implementation of automation in the laundry sector, are driving the growth of the commercial laundry market. Furthermore, growing urbanization, changing consumer purchasing patterns, and increasing digitalization, all favor the market. According to SkyQuest’s survey, commercial laundry services help the healthcare and hospitality industries save 30% to 40% of their cost spent on water and power utilities, allowing them to spend this money on their core services. Rapid...

Introduction of Diversified Product Portfolio to Help Bubble Tea Market Reach USD 5.5 billion by 2028

Written by Customer Service on January 9, 2023. Posted in Mergers And Acquisitions.

The bubble tea market reached USD 3.5 billion in 2021 and is predicted to cross USD 5.5 billion by 2028, growing at a 7.6% CAGR during the forecast period (2022–2028). Westford, USA, Jan. 09, 2023 (GLOBE NEWSWIRE) — The growing popularity of tea and coffee as nootropic liquids among students and working-class people is one of the key drivers for the industry’s expansion. In addition, such beverages’ zero-fat and low-calorie contents are gaining preference among the health-conscious population, eventually driving up product demand. As per SkyQuest’s research insights, youngsters ages 20 to 29 are the prime consumer of bubble tea. If there’s one trend worth noticing, bubble tea is likely to gain more preference among women than men. In the United States, 95% of women have tried bubble tea, as opposed to 81%...

Branded Legacy, Inc. Buys Back Over 17 Million Free Trading Common Shares

Written by Customer Service on January 9, 2023. Posted in Public Companies.

Company Continues to Lower Share Structure Charlotte, NC , Jan. 09, 2023 (GLOBE NEWSWIRE) — Branded Legacy, Inc. (OTC: BLEG), a holding company focused on the commercial development of cannabinoid-infused products from CBD topicals and tinctures to edibles is pleased to announce it has negotiated the reduction of its float by Seventeen Million Five Hundred and Twenty Thousand (17,520,000) free trading common shares. Brandon Spikes, chairman of Branded Legacy, Inc., stated, “We have continuously been working on share structure over the last several months. In doing so, last week have bought back 17,520,000 free trading shares out of the float, in exchange for a non-convertible promissory note. This is huge for our shareholders.” Spikes concluded, “In the past six months we successfully reduced our issued and outstanding...

Wolters Kluwer acquires NurseTim

Written by Customer Service on January 9, 2023. Posted in Mergers And Acquisitions.

Wolters Kluwer acquires NurseTim Enhances portfolio of nursing education solutions Alphen aan den Rijn, January 9, 2023 — Wolters Kluwer Health today announced it has signed and completed an agreement to acquire NurseTim, a US-based provider of nursing education solutions. NurseTim will become part of Wolters Kluwer’s Health Learning, Research & Practice (HLRP) business, which includes nursing education and practice solutions that help ensure students are ready for practice and nurses are prepared to deliver better patient care and outcomes. NurseTim’s NurseThink provides a set of test preparation tools for faculty and students to prepare candidates for the Next Generation National Council Licensure Examination (NCLEX) in the U.S. In addition, the company provides hands-on nurse faculty training through conferences and webinars....

Sotherly Hotels Inc. Reports Preliminary Operating Results for the Fourth Quarter Ended December 31, 2022

Written by Customer Service on January 9, 2023. Posted in Public Companies.

WILLIAMSBURG, Va., Jan. 09, 2023 (GLOBE NEWSWIRE) — Sotherly Hotels Inc. (NASDAQ: SOHO), (“Sotherly” or the “Company”), a self-managed and self-administered lodging real estate investment trust (a “REIT”), today reported preliminary operating results for the Company’s ten wholly-owned properties, (“same-store” portfolio metrics). Accordingly, the actual data does not include the participating condominium hotel rooms of the Hyde Resort & Residences and the Hyde Beach House, the Sheraton Louisville Riverside, or the DoubleTree by Hilton Raleigh Brownstone. Preliminary same-store portfolio metrics for the fourth quarter 2022 were as follows: October Results December Results Oct-22 % Variance to 2021 % Variance to 2019 Dec-22 % Variance to 2021 % Variance to 2019Occupancy 69.9% 16.6% -8.6% Occupancy 48.1% 4.8% -14.4%ADR $186.12 12.9% 12.0% ADR $169.69 8.9% 18.6%RevPAR $129.16 31.6% 2.6% RevPAR $80.75 13.7% 1.3% November...

ACV Takes the Stage in Dallas at the 2023 National Automobile Dealers Association Show

Written by Customer Service on January 9, 2023. Posted in Public Companies.

ACV experts in dealership operations and data technology will host educational workshop and compete in new Pitch Competition BUFFALO, N.Y., Jan. 09, 2023 (GLOBE NEWSWIRE) — ACV (Nasdaq: ACVA), the leading digital automotive marketplace and data services partner for dealers and commercial partners, will be exhibiting at the 2023 National Automobile Dealers Association (NADA) Show, while also hosting its first educational workshop and appearing in the show’s first-ever Exhibitor Pitch Competition. On Thursday, January 26, at 1:00 p.m. CT, Vice President of Business Development Randy Barone will lead an educational workshop on the Variable Operations track: “Windshield or Rear-view Mirror? How do you manage used cars?” Barone, a 30-year automotive industry veteran and former dealer, will focus on inventory management strategies. Attendees...

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2022

Written by Customer Service on January 9, 2023. Posted in Earnings Releases And Operating Results.

Fourth Quarter revenue of $31.7 – $31.9 million representing growth of approximately 26%Fiscal Year 2022 revenue of $106.1 – $106.3 million representing growth of approximately 18% SANTA CLARA, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced its preliminary and unaudited revenue for fourth quarter and full year 2022. Fourth Quarter 2022 SummaryWorldwide revenue expected to be in the range of $31.7-$31.9 million, representing growth of approximately 26% compared to the prior year period U.S. revenue expected to be in the range of $29.8-$29.9 million, representing growth of approximately 28% compared to the prior year period Ended the quarter with a record 920 active surgeons in...

AmmPower Corp. Completes Acquisition of 50.05% of the Common Shares of Progressus Clean Technologies, Inc.

Written by Customer Service on January 9, 2023. Posted in Mergers And Acquisitions.

TORONTO, Jan. 09, 2023 (GLOBE NEWSWIRE) — AmmPower Corp. (CSE:AMMP, OTCQB:AMMPF, FSE:601A) (the “Company” or “AmmPower“) is pleased to announce, further to its news release dated December 30, 2022, that it has completed the acquisition (the “Acquisition”) of 50.05% of the issued and outstanding common shares of Progressus Clean Technologies, Inc. (“Progressus”), from certain former shareholders of Progressus (the “Vendors”). In consideration for the Acquisition, the Company issued an aggregate of 50,000,000 common shares in the capital of the Company (the “Company Shares”) to the Vendors at a deemed price of C$0.30 per Company Share. In connection with the Acquisition, the Vendors agreed to provide to the Company an aggregate loan of $500,000 payable as follows: (a) $250,000 provided on January 6, 2023 (the...

Royalty Pharma Announces Dividend Increase

Written by Customer Service on January 9, 2023. Posted in Dividend Reports And Estimates.

NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2023 of $0.20 per Class A share, reflecting a 5.3% increase in the company’s quarterly dividend over the previous quarter’s dividend. The dividend will be paid on March 15, 2023 to shareholders of record at the close of business on February 16, 2023. “We are pleased to once again announce an increase to our dividend,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “We are committed to returning capital to our shareholders through our attractive dividend while retaining financial flexibility to fund innovation. We continue to see significant opportunities for value-enhancing growth as the demand for capital in the biopharma ecosystem...

Sorrento Releases Positive Results from a Phase 1b Study in China in COVID-19 Patients and is Ready for Pivotal Phase 3 trials with OVYDSO™ (STI-1558), an Oral Mpro Inhibitor as a Standalone Treatment for COVID-19 without the Need for Ritonavir Boosting

Written by Customer Service on January 9, 2023. Posted in Public Companies.

Topline safety, antiviral effectiveness and pharmacokinetic (PK) data from a Phase 1b Study in China are released from the single ascending dose (SAD) portion of the study with the doses from 300 mg to 2,000 mg in 32 healthy volunteers and the multiple ascending dose (MAD) portion of the study in 46 COVID-19 patients with 300 mg BID, 600 mg BID and 800 mg BID daily dosing for 7.5 days. Overall, STI-1558 was well-tolerated at all doses tested, with most subjects in both the SAD and MAD portions of the study reporting no adverse events (AEs). There was no dose limiting toxicity during the study. There were no severe or serious AEs, no premature discontinuations of STI-1558 due to an AE, and no deaths. Most AEs were mild, unrelated and required no medical treatment. In the MAD portion of the study (n=41 evaluable), COVID-19 patients (n=29)...

Month: January 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals